Latest news and stories at your screen

Advertisement
Advertisement

Actelion's ambitious independent-minded CEO will drive up takeover price



Business

by Reuters Business 0 Comments

Actelion Chief Executive Jean-Paul Clozel's desire to keep Europe's biggest biotech company independent after building it from scratch, means Johnson & Johnson will have to pay a steep premium if a takeover is to succeed.

Read Full Post
Advertisement

Comments

Latest Posts in Business

9 days ago

Markets Live: Trump shine fades

Shares set for a flat start as investors globally fret over Italy's banking system, while iron ore pushes above $US80.

9 days ago

Australian market set to open up

THE Australian market looks set to open slightly higher despite Wall Street falling, weighed down by financial and consumer discretionary stocks as some investors cashed in following a record-setting week.

NewsThrive

NewsThrive

Subscribe